News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
398,055 Results
Type
Article (32050)
Company Profile (58)
Press Release (365947)
Multimedia
Podcasts (42)
Webinars (5)
Section
Business (112834)
Career Advice (1323)
Deals (24048)
Drug Delivery (94)
Drug Development (59729)
Employer Resources (104)
FDA (9958)
Job Trends (9091)
News (211594)
Policy (25534)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1843)
Accelerated approval (4)
Adcomms (20)
Allergies (68)
Alliances (42284)
ALS (59)
Alzheimer's disease (1110)
Antibody-drug conjugate (ADC) (100)
Approvals (9954)
Artificial intelligence (160)
Autoimmune disease (17)
Automation (7)
Bankruptcy (237)
Best Places to Work (7695)
BIOSECURE Act (16)
Biosimilars (83)
Biotechnology (42)
Bladder cancer (57)
Brain cancer (27)
Breast cancer (188)
Cancer (1645)
Cardiovascular disease (128)
Career advice (1114)
Career pathing (20)
CAR-T (106)
Cell therapy (296)
Cervical cancer (16)
Clinical research (48261)
Collaboration (684)
Compensation (433)
Complete response letters (19)
COVID-19 (2478)
CRISPR (30)
C-suite (114)
Cystic fibrosis (58)
Data (1551)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (217)
Diagnostics (3573)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (88)
Drug pricing (97)
Drug shortages (28)
Duchenne muscular dystrophy (84)
Earnings (40393)
Editorial (36)
Employer branding (13)
Employer resources (94)
Events (45906)
Executive appointments (323)
FDA (10814)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (481)
Gene editing (73)
Generative AI (13)
Gene therapy (238)
GLP-1 (692)
Government (4101)
Grass and pollen (5)
Guidances (36)
Healthcare (11414)
Huntington's disease (19)
IgA nephropathy (24)
Immunology and inflammation (86)
Indications (24)
Infectious disease (2619)
Inflammatory bowel disease (78)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (73)
Interviews (231)
IPO (10442)
IRA (40)
Job creations (1750)
Job search strategy (956)
Kidney cancer (7)
Labor market (18)
Layoffs (280)
Leadership (9)
Legal (7060)
Liver cancer (52)
Lung cancer (239)
Lymphoma (112)
Machine learning (6)
Management (32)
Manufacturing (224)
MASH (56)
Medical device (5927)
Medtech (5928)
Mergers & acquisitions (14019)
Metabolic disorders (596)
Multiple sclerosis (52)
NASH (20)
Neurodegenerative disease (70)
Neuropsychiatric disorders (25)
Neuroscience (1499)
NextGen: Class of 2025 (3657)
Non-profit (2770)
Northern California (1649)
Now hiring (5)
Obesity (338)
Opinion (194)
Ovarian cancer (53)
Pain (49)
Pancreatic cancer (66)
Parkinson's disease (114)
Partnered (13)
Patents (166)
Patient recruitment (60)
Peanut (38)
People (24890)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14586)
Phase II (20965)
Phase III (17003)
Pipeline (904)
Policy (131)
Postmarket research (1846)
Preclinical (6063)
Press Release (28)
Prostate cancer (82)
Psychedelics (28)
Radiopharmaceuticals (205)
Rare diseases (269)
Real estate (2584)
Recruiting (44)
Regulatory (16165)
Reports (22)
Research institute (1592)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (3)
RSV (47)
Schizophrenia (60)
Series A (79)
Series B (43)
Service/supplier (4)
Sickle cell disease (38)
Southern California (1353)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (19)
Startups (1887)
State (1)
Stomach cancer (11)
Supply chain (54)
Tariffs (27)
The Weekly (32)
United States (13383)
Vaccines (712)
Venture capitalists (28)
Weight loss (248)
Women's health (13)
Worklife (10)
Date
Today (128)
Last 7 days (503)
Last 30 days (1602)
Last 365 days (21078)
2025 (6541)
2024 (22354)
2023 (25258)
2022 (33388)
2021 (35891)
2020 (34080)
2019 (27911)
2018 (21242)
2017 (20192)
2016 (18693)
2015 (21495)
2014 (15949)
2013 (12877)
2012 (13624)
2011 (14403)
2010 (13079)
Location
Africa (570)
Alabama (30)
Alaska (3)
Arizona (91)
Arkansas (5)
Asia (25943)
Australia (4679)
California (3602)
Canada (1221)
China (363)
Colorado (154)
Connecticut (160)
Delaware (102)
Europe (62235)
Florida (547)
Georgia (125)
Hawaii (1)
Idaho (28)
Illinois (290)
India (23)
Indiana (191)
Iowa (8)
Japan (119)
Kansas (61)
Kentucky (15)
Louisiana (10)
Maine (28)
Maryland (644)
Massachusetts (2597)
Michigan (101)
Minnesota (139)
Mississippi (1)
Missouri (50)
Montana (20)
Nebraska (10)
Nevada (38)
New Hampshire (20)
New Jersey (1139)
New Mexico (15)
New York (1090)
North Carolina (507)
North Dakota (4)
Northern California (1649)
Ohio (113)
Oklahoma (6)
Oregon (10)
Pennsylvania (789)
Puerto Rico (5)
Rhode Island (13)
South America (797)
South Carolina (11)
South Dakota (1)
Southern California (1353)
Tennessee (52)
Texas (442)
Utah (82)
Virginia (92)
Washington D.C. (37)
Washington State (304)
West Virginia (2)
Wisconsin (27)
398,055 Results for "octapharma ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding
April 2, 2025
·
4 min read
Press Releases
Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
December 11, 2024
·
2 min read
Octapharma’s continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
The most recent developments from Octapharma’s Haematology portfolio will be presented at the 32nd Congress of the International Society on Thrombosis and Haemostasis on June 22–26, 2024, in Bangkok, Thailand.
June 10, 2024
·
9 min read
FDA
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD
Octapharma USA , Inc. announced the U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease (VWD).
April 29, 2024
·
4 min read
Business
Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development
Octapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing team as the company continues to grow its presence in the U.S. market.
May 20, 2024
·
2 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Policy
Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures
Octapharma USA has announced Balfaxar® is now available. The new non-activated four factor prothrombin complex concentrate, approved by the U.S. FDA this summer, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy in adult patients with need for urgent surgery or invasive procedures.
January 3, 2024
·
5 min read
Pharm Country
Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD
Octapharma USA announced the expansion of the U.S. Food and Drug Administration (FDA) approval for wilate ® , von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection.
December 5, 2023
·
5 min read
Press Releases
Additional Member for the Board of Directors of Bachem Holding AG
April 3, 2025
·
3 min read
Press Releases
Luminopia Announces FDA Clearance for Patients with Amblyopia Aged 8 to 12 Years
April 22, 2025
·
5 min read
1 of 39,806
Next